Literature DB >> 4783632

The metabolism of tamoxifen (I.C.I. 46,474). II. In female patients.

J M Fromson, S Pearson, S Bramah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4783632     DOI： 10.3109/00498257309151595

Source DB:  PubMed          Journal:  Xenobiotica        ISSN： 0049-8254            Impact factor:   1.908


× No keyword cloud information.
  17 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 2.  Mass balance studies, with a focus on anticancer drugs.

Authors:  Jan H Beumer; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 3.  Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 4.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

Review 5.  Pharmacokinetics of selective estrogen receptor modulators.

Authors:  Karla C Morello; Gregory T Wurz; Michael W DeGregorio
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer.

Authors:  P Wilkinson; G Ribeiro; H Adam; J Patterson
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 7.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 8.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

Review 9.  Tamoxifen as adjuvant therapy in breast cancer. Current status.

Authors:  P N Plowman
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 10.  Selective estrogen receptor modulators and phytoestrogens.

Authors:  Tawakalitu Oseni; Roshani Patel; Jennifer Pyle; V Craig Jordan
Journal:  Planta Med       Date:  2008-10-08       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.